Protalix BioTherapeutics (PLX) EBIT Margin (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,634.00 |
| Dec 31, 2025 | -1,562.00 |
| Sep 30, 2025 | 445.00 |
| Jun 30, 2025 | 4,847.00 |
| Mar 31, 2025 | -8,056.00 |
| Dec 31, 2024 | 1,735.00 |
| Sep 30, 2024 | 4,024.00 |
| Jun 30, 2024 | 11,155.00 |
| Mar 31, 2024 | -7,601.00 |
| Dec 31, 2023 | -3,531.00 |
| Sep 30, 2023 | -7,646.00 |
| Jun 30, 2023 | 8,387.00 |
| Mar 31, 2023 | -11,264.00 |
| Dec 31, 2022 | 10,902.00 |
| Sep 30, 2022 | 4,108.00 |
| Jun 30, 2022 | -5,148.00 |
| Mar 31, 2022 | 5,512.00 |
| Dec 31, 2021 | -5,111.00 |
| Sep 30, 2021 | 12,698.00 |
| Jun 30, 2021 | -10,989.00 |
| Mar 31, 2021 | -4,729.00 |
| Dec 31, 2020 | 3,849.00 |
| Sep 30, 2020 | -350.00 |
| Jun 30, 2020 | -4,211.00 |
| Mar 31, 2020 | 594.00 |
| Dec 31, 2019 | 2,657.00 |
| Sep 30, 2019 | 3,684.00 |
| Jun 30, 2019 | 534.00 |
| Mar 31, 2019 | 15,610.00 |
| Dec 31, 2018 | 35,514.00 |
| Sep 30, 2018 | -22,806.00 |
| Jun 30, 2018 | -22,306.00 |
| Mar 31, 2018 | 41,920.00 |
| Dec 31, 2017 | -42,916.00 |
| Sep 30, 2017 | 6,677.00 |
| Jun 30, 2017 | 21,675.00 |
| Mar 31, 2017 | 3,233.00 |
| Dec 31, 2016 | -27,667.00 |
| Sep 30, 2016 | 41,904.00 |
| Jun 30, 2016 | 59,678.00 |
| Sep 30, 2015 | 4,356.00 |
| Jun 30, 2015 | -9,976.00 |
| Mar 31, 2014 | -30,723.00 |
| Dec 31, 2013 | 45,779.00 |
| Sep 30, 2013 | 5,735.00 |
| Jun 30, 2013 | -18,037.00 |
| Mar 31, 2013 | 74,336.00 |
| Dec 31, 2012 | -71,819.00 |
| Sep 30, 2012 | -18,614.00 |
| Jun 30, 2012 | 19,392.00 |
| Mar 31, 2012 | 21,794.00 |
| Dec 31, 2011 | 39,945.00 |
| Sep 30, 2011 | 104,071.00 |
| Jun 30, 2011 | -169,314.00 |
| Mar 31, 2011 | 63,034.00 |
| Dec 31, 2010 | -66,293.00 |
| Sep 30, 2010 | 80,012.00 |